Barry H. Evenchick, Partner at Pashman Stein Walder Hayden,
Named Chief Counsel to Hereditary Disease Foundation
NEW YORK (October 1, 2020) – The Hereditary Disease Foundation (HDF), which funds scientific research to find treatments and cures for Huntington’s disease, has named Barry H. Evenchick Chief Counsel. Mr. Evenchick is a partner at the New Jersey-based law firm Pashman Stein Walder Hayden where his practice focuses on litigation.
Mr. Evenchick is a former prosecutor, having served as chief
of the appellate section of the Essex County Prosecutor’s Office
and as the first chief of the appellate section of the New Jersey
Division of Criminal Justice. He also served for 12 years as the
municipal attorney of the Township of Livingston and for six
years as a commissioner of the New Jersey State Commission
of Investigation. He is an adjunct faculty member of Rutgers
Law School in Newark and serves as vice-chair of the editorial
board of the New Jersey Law Journal. He is a member of the
HDF Board of Directors.
“We are privileged to have Mr. Evenchick’s expertise as we ramp up our funding of innovative research into treatments for Huntington’s disease. I look forward to working with him in his new capacity as Chief Counsel,” said Meghan Donaldson, CEO of the Hereditary Disease Foundation.
Mr. Evenchick said, “It is a particular honor to be named Chief Counsel at this time when the Hereditary Disease Foundation has just launched the Nancy S. Wexler Discovery Fund and named the first recipient of the Nancy S. Wexler Young Investigator Prize. This is an exciting period as we expand our efforts to support research that is making a difference in the lives of Huntington’s disease patients and their families.”
About the Hereditary Disease Foundation
The Hereditary Disease Foundation facilitates collaborative and innovative scientific research to further the understanding of Huntington’s disease, a genetic disorder that strikes in early- to mid-adulthood, destroying brain cells and bringing on severe and progressive declines in personality, cognitive ability, and mobility. As a disease caused by a mistake on a single gene, Huntington’s disease serves as an ideal model for understanding other brain disorders. Research organized by the Foundation led to the discovery of the genetic marker for Huntington’s disease in 1983. HDF organized and funded a decade-long international collaboration of over 100 scientists who discovered the gene that causes Huntington’s in 1993. This work played an important role in the development of the Human Genome Project. For information, visit http://www.hdfoundation.org.
About Pashman Stein Walder Hayden
Pashman Stein Walder Hayden is a full-service law firm of 60 attorneys with a reputation for professional excellence. Headquartered in Hackensack, New Jersey with offices in Monmouth County, New Jersey, and Westchester County, New York, the firm serves a diverse client base including Fortune 500 companies, emerging growth entities, businesses, other law firms, and individuals throughout New Jersey and the New York metropolitan area. Named a Regional Powerhouse in 2018 by Law360, awarded Appellate Litigation Department of the Year (2020) by the New Jersey Law Journal, and recognized by Chambers USA 2020 as one of the top law firms in New Jersey in the fields of General Commercial Litigation and White-Collar Crime & Government Investigations, Pashman Stein and its lawyers continue to be recognized for sophisticated legal skills and experience. For more information, please visit www.pashmanstein.com.
Barry H. Evenchick